Clinical Trials Browser

Terminated × Immunoblastic Lymphadenopathy × Cyclosporine × Clear all

NCT00070291 2023-06-29

Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma

Phase 2 Terminated

4 enrolled 6 charts

Immunoblastic Lymphadenopathy, Lymphoma